DCM
LEGN icon

Dupont Capital Management’s Legend Biotech LEGN Stock Holding History

Dupont Capital Management’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-4,331
Closed -$216K – 1000
2022
Q4 		$216K Buy
+4,331
New +$210K 0.01% 769

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Dupont Capital Management's LEGN Position: Q1 2023 in Review

Dupont Capital Management sold out of Legend Biotech (LEGN) in Q1 2023, closing a stake of 4,331 shares — an estimated $216K sold.

Dupont Capital Management first reported a position in LEGN in Q4 2022 and held it in 1 quarter. The position peaked at $216K in Q4 2022. 160 funds tracked by Wall St. Rank hold LEGN as of Q1 2023.

  • Dupont Capital Management reported no remaining Legend Biotech position as of Q1 2023 after selling out during the quarter.
  • Dupont Capital Management sold 4,331 Legend Biotech shares in Q1 2023, an estimated $216K.
  • Dupont Capital Management first reported a position in Legend Biotech in Q4 2022 and held it in 1 quarter.
  • Dupont Capital Management's Legend Biotech position peaked at $216K in Q4 2022.
  • 160 funds tracked by Wall St. Rank held Legend Biotech as of Q1 2023.

Based on Dupont Capital Management's 13F filing for Q1 2023, filed 28 Apr 2023.